Information Provided By: 
Fly News Breaks for July 6, 2015
ALDR
Jul 6, 2015 | 08:19 EDT
Bernstein increased its price target on Alder as the company's secondary offering increased its share count by less than the firm had forecast, while Bernstein now believes that Alder's ALD403 drug has a 65% chance of success, up from 60% previously. The firm keeps an Outperform rating on Alder.
News For ALDR From the Last 2 Days
There are no results for your query ALDR
